U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H23NO
Molecular Weight 233.3492
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-ETHYL-1-(3-METHOXYPHENYL)CYCLOHEXANAMINE

SMILES

CCNC1(CCCCC1)C2=CC=CC(OC)=C2

InChI

InChIKey=OFGOOZLOGUNDFS-UHFFFAOYSA-N
InChI=1S/C15H23NO/c1-3-16-15(10-5-4-6-11-15)13-8-7-9-14(12-13)17-2/h7-9,12,16H,3-6,10-11H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C15H23NO
Molecular Weight 233.3492
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:16:20 UTC 2023
Edited
by admin
on Sat Dec 16 10:16:20 UTC 2023
Record UNII
PX6CYK9I4H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-ETHYL-1-(3-METHOXYPHENYL)CYCLOHEXANAMINE
Systematic Name English
N-ETHYL-1-(3-METHOXYPHENYL)CYCLOHEXAN-1-AMINE
Systematic Name English
3-METHOXY-PCE
Common Name English
3-MEO-PCE
Common Name English
CYCLOHEXANAMINE, N-ETHYL-1-(3-METHOXYPHENYL)-
Systematic Name English
3-MEO-PCE [NFLIS-DRUG]
Common Name English
3-METHOXY ETICYCLIDINE
Common Name English
3-METHOXYETICYCLIDINE
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-3-MeO-PCE
Created by admin on Sat Dec 16 10:16:20 UTC 2023 , Edited by admin on Sat Dec 16 10:16:20 UTC 2023
Code System Code Type Description
PUBCHEM
57461569
Created by admin on Sat Dec 16 10:16:20 UTC 2023 , Edited by admin on Sat Dec 16 10:16:20 UTC 2023
PRIMARY
FDA UNII
PX6CYK9I4H
Created by admin on Sat Dec 16 10:16:20 UTC 2023 , Edited by admin on Sat Dec 16 10:16:20 UTC 2023
PRIMARY
WIKIPEDIA
3-MEO-PCE
Created by admin on Sat Dec 16 10:16:20 UTC 2023 , Edited by admin on Sat Dec 16 10:16:20 UTC 2023
PRIMARY 3-Methoxyeticyclidine (3-MeO-PCE) is a dissociative anesthetic drug that has been sold online as a designer drug.[1] The activity of 3-MeO-PCE in humans was not described until 1999 when a chemist using the pseudonym John Q. Beagle wrote that 3-MeO-PCE was qualitatively similar to PCP. 3-MeO-PCE has a Ki of 61 nM for the NMDA receptor, 115 nM for the serotonin transporter, 4519 nM for the sigma1 receptor and 525 nM for the sigma2 receptor.
EPA CompTox
DTXSID701032419
Created by admin on Sat Dec 16 10:16:20 UTC 2023 , Edited by admin on Sat Dec 16 10:16:20 UTC 2023
PRIMARY
CAS
1364933-80-1
Created by admin on Sat Dec 16 10:16:20 UTC 2023 , Edited by admin on Sat Dec 16 10:16:20 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT